Outcomes of Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation by Using a Standard Myeloablative versus a Novel Reduced-Toxicity Conditioning Regimen According to a New Risk Stratification
2014 ◽
Vol 20
(12)
◽
pp. 2066-2071
◽
2015 ◽
Vol 21
(2)
◽
pp. S239
2016 ◽
Vol 4
(4)
◽
pp. 667-671
◽
2012 ◽
Vol 29
(7)
◽
pp. 585-594
◽
2016 ◽
Vol 22
(8)
◽
pp. 1391-1396
◽
2004 ◽
Vol 33
(8)
◽
pp. 789-792
◽
2017 ◽
Vol 23
(11)
◽
pp. 1918-1924
◽